參考資料 :

  1. Mercilon Prescribing Information. Organon Hong Kong. 2021
  2. Lammers P and Op Ten Berg M. Phase III clinical trial with anew oral contcroancteaipntiinvge150 ug desogestrel and 20 ug ethinylestradiol. Acta Obstet Gynecol Scand. 1991:70:497-500
  3. WHO Family planning- A global handbook for providers. 2022 Edition. Available from: https://www.who.int/publications/i/item/9780999203705. [Accessed 3Nov 2023).
  4. Marvelon Prescribing Information. Organon Hong Kong. 2021.
  5. Bilotta P&Favilli S. Clinical Evaluation of a Monophasic Ethinylestradiol/ Desogestrel-containing Oral Contraceptive. Arzneim. Forsch. 1988;38(1)7:932-4.
  6. Data on file.
  7. Teal S &Edelman A. Contraception SEefflecttivioene, ss, and Adverse Effects. JAMA. 2021;326(24): 2507-8.
  8. Yang M & Li Z. The development history of oral contraceptives. Zhonghua Vi Shi Za Zhi. 2021;51(2):92-6.
  9. American College of Obstetricians and Gynecologists. Emergency Contraception. Available from: https://www.acog.org/womens-health/faqs/emergency-contraception. [Accessed 3Nov 2023].